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Abstract 
 
 Mycetoma is a major health problem, in tropical and 
subtropical areas.  It is dreadfully neglected by both society and 
health communities across the world.  It affects the poor in Sudan 
and many other developing countries.  A lot of studies had been 
done about mycetoma in adult, but none of them concentrated on 
infection among children.  So there are insufficient studies done 
about mycetoma in children found in the literature and in the 
internet, both in Sudan and in the globe. 
 This is a prospective descriptive hospital based study.  It was 
conducted at mycetoma Research Centre at Soba University 
Hospital.  It aimed to study the clinical presentation of mycetoma 
in children and the knowledge, attitude and practice towards the 
disease. 
 The study period was six months.  During this period 110 
cases of mycetoma in children less than 18 years of age were 
reported.  Each patient was interviewed using a questionnaire.  The 
questionnaire contained personal data about the patients, clinical 
history and local and general examination of each patient and 
modalities of investigations used for diagnosis.  The second point 
of the questionnaire contained questions about their knowledge, 
attitude and practice towards the disease. 
 The study revealed that mycetoma affect the poor in Sudan.   
The male predominate female by 3: 1.  The majority of patient 
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(54.5%) between 15-18 years, 39.1% from 10-14 years and 6.4% from 
5-9 years of age. 
 The disease prevails in the central part of Sudan (91%).  
Fungal mycetoma is the main type (95.5%).  The lower limb is the 
commonest affected site (68%) and the left foot is more commonly 
affected than the right (44%).  The majority seek medical advice 
after one year of infection (68.2%), and 62.7% of them present to the 
centre after recurrence.  65.4% presented with both sinuses and 
masses.  31.8% of the study group had bone infection.  39.1% had 
family history of mycetoma.  60.9% of them gave no history of 
previous trauma. 
 86.4% of patients had some knowledge about the disease and 
all of them took their knowledge from their treating doctors. 
 The cost of treatment is very expensive for  (65.5%).  So 32.7% 
of the study group used traditional treatment before seeking 
medical advice. 
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  ﻣﻠﺨﺺ اﻻﻃﺮوﺣﺔ
 
 
ﺗﻌﺪ اﻟﻤﺎﻳﺴﺘﻮﻣﺎ ﻣﻦ اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ اﻻﺳﺎﺳﻴﺔ ﻓﻲ آﻞ اﻟﻤﻨﺎﻃﻖ اﻟﺤﺎرﻩ وﺷﺒﻪ اﻟﺤﺎرة وﻋﻠﻲ  
وهﻮ ﻣﺮض .  ت اﻟﻤﺤﻠﻴﺔ واﻟﺼﺤﻴﺔ ﻓﻲ آﻞ اﻟﻌﺎﻟﻢاﻟﺮﻏﻢ ﻣﻦ ذﻟﻚ ﻓﻬﻮ ﻣﺮض ﻣﻬﻤﻞ ﻣﻦ ﻗﺒﻞ اﻟﻤﺠﺘﻤﻌﺎ
ﻳﺖ ﺣﻮل هﺬا   هﻨﺎﻟﻚ ﻋﺪة دراﺳﺎت اﺟﺮ-ﻳﺼﻴﺐ اﻻﻗﻠﻴﺎت اﻟﻔﻘﻴﺮة ﻓﻲ اﻟﺴﻮدان وﻣﺨﺘﻠﻒ اﻟﺪول اﻟﻨﺎﻣﻴﺔ 
اﻟﻤﺮض وﻗﺪ رآﺰ اﻏﻠﺒﻬﺎ ﻋﻠﻲ ﺣﺪوث اﻟﻤﺮض ﻓﻲ اﻟﻜﺒﺎر وﻟﻢ ﺗﺮآﺰ اﺣﺪي هﺬﻩ اﻟﺪراﺳﺎت ﻋﻠﻲ 
وﻟﻬﺬا اﻟﺴﺒﺐ ﻟﻢ ﺗﻮﺟﺪ دراﺳﺎت آﺎﻓﻴﺔ ﻓﻲ اﻟﻤﺮاﺟﻊ او ﻓﻲ اﻻﻧﺘﺮﻧﺖ ﻋﻦ ﺣﺪوث .  ﺣﺪوﺛﻪ ﻓﻲ اﻻﻃﻔﺎل 
  . ﻓﻲ اﻟﺴﻮدان واﻟﻌﺎﻟﻢ اﻟﻤﺎﻳﺴﺘﻮﻣﺎ ﻓﻲ اﻻﻃﻔﺎل
ﻓﻲ ﻣﺮآﺰ اﺑﺤﺎث اﻟﻤﺎﻳﺴﺘﻮﻣﺎ ﺑﻤﺴﺘﺸﻔﻲ ﺳﻮﺑﺎ اﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ اﻟﻤﺴﺘﻘﺒﻠﻴﺔ اﻟﻮﺻﻔﻴﺔ   
 ﺳﻨﺔ ودراﺳﺔ اﻟﻤﻌﺮﻓﺔ واﻟﻤﻮاﻗﻒ 81اﻟﺠﺎﻣﻌﻲ ﺑﻐﺮض دراﺳﺔ ﺣﺪوث اﻟﻤﺎﻳﺴﺘﻮﻣﺎ ﻓﻲ اﻻﻃﻔﺎل اﻗﻞ ﻣﻦ 
 .واﻟﻤﻤﺎرﺳﺎت ﺗﺠﺎﻩ هﺬا اﻟﻤﺮض 
 ﻃﻔﻞ ﻣﺼﺎﺑﺎ ﺑﺎﻟﻤﺎﻳﺴﺘﻮﻣﺎ ﻟﻌﻤﺮ اﻗﻞ ﻣﻦ 011وﺷﻤﻠﺖ  ﺷﻬﻮر 6اﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻓﻲ ﻓﺘﺮة  
ﻜﻞ ﻣﺮﻳﺾ وﻳﺤﺘﻮي هﺬا اﻻﺳﺘﺒﻴﺎن ﻋﻠﻲ ﻣﻌﻠﻮﻣﺎت ﻋﻦ اﻟﻤﺮﻳﺾ ﺣﻴﺚ ﺗﻢ ﻣﻞء اﺳﺘﺒﻴﺎن ﻟ,  ﺳﻨﺔ81
واﺧﺬ اﻟﺘﺎرﻳﺦ اﻟﻤﺮﺿﻲ واﻻﻋﺮاض اﻟﺴﺮﻳﺮﻳﺔ ﻟﻠﻤﺮض وﻓﺤﺺ اﻟﻤﺮﻳﺾ ﺳﺮﻳﺮﻳﺎ وﻣﺮاﺟﻌﺔ 
اﻟﻔﺤﻮﺻﺎت اﻟﻌﺎﻣﺔ واﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺸﺨﻴﺺ واﻟﻤﺘﺎﺑﻌﺔ وﺑﻌﺾ اﻻﺳﺌﻠﺔ ﻋﻦ ﻣﻌﺮﻓﺔ اﻟﻤﺮﻳﺾ وأﻗﺎرﺑﻪ 
  .ﻋﻦ اﻟﻤﺮض وﻣﻮاﻗﻔﻬﻢ وﻣﻤﺎرﺳﺘﻬﻢ ﺗﺠﺎهﻪ
ﻟﻤﺎﻳﺴﺘﻮﻣﺎ ﻳﺼﻴﺐ اﻟﻔﺌﺎت اﻟﻔﻘﻴﺮة ﻓﻲ اﻟﺴﻮدان وان ﻧﺴﺒﺔ اﻻﺻﺎﺑﺔ اوﺿﺤﺖ اﻟﺪراﺳﺔ ان ا  
 81-51 وان اﻋﻠﻲ ﻧﺴﺒﺔ اﺻﺎﺑﺔ ﻓﻲ اﻻﻃﻔﺎل ﻣﺎﺑﻴﻦ 1:3اﻋﻠﻲ ﻋﻨﺪ اﻟﺬآﻮر ﻋﻨﻬﻢ ﻓﻲ اﻻﻧﺎث ﺑﻨﺴﺒﺔ 
% 1.93 ﺳﻨﺔ ﺑﻠﻐﺖ 41-01 ﺑﻴﻨﻤﺎ ﻧﺴﺒﺔ اﻻﺻﺎﺑﺔ ﻓﻲ اﻻﻃﻔﺎل ﻣﺎﺑﻴﻦ -% 5.45ﺳﻨﺔ ﺑﻨﺴﺒﺔ ﺗﺒﻠﻎ 
 آﻤﺎ اوﺿﺤﺖ اﻟﺪراﺳﺔ ان وﺳﻂ اﻟﺴﻮدان اآﺜﺮ –ﻨﻮات  ﺳ01ﻓﻲ اﻻﻃﻔﺎل اﻗﻞ ﻣﻦ % 4,6وﺣﻮاﻟﻲ 
  %.19اﻟﻤﻨﺎﻃﻖ اﺻﺎﺑﺔ ﺑﺎﻟﻤﺮض ﺑﻨﺴﺒﺔ 
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وان اﻟﻘﺪم هﻲ اآﺜﺮ اﻻﻣﺎآﻦ % 5.59وان اﻟﻤﺎﻳﺴﺘﻮﻣﺎ اﻟﻔﻄﺮﻳﺔ هﻲ اﻟﻤﺴﺒﺐ اﻟﺮﺋﻴﺲ ﻧﺴﺒﺔ   
  %.  44وان اﻟﻘﺪم  اﻻﻳﺴﺮ اآﺜﺮ ﻋﺮﺿﻪ ﻟﻼﺻﺎﺑﺔ ﺑﻨﺴﺒﺔ % 86ﻋﺮﺿﺔ ﻟﻼﺻﺎﺑﺔ ﺑﻨﺴﺒﺔ 
ﻃﻠﺒﻮا اﻟﻤﺸﻮرﻩ اﻟﺼﺤﻴﺔ ﺑﻌﺪ اﻻﺻﺎﺑﺔ % 2.86 ﺒﺔ وﻗﺪ اوﺿﺤﺖ اﻟﺪراﺳﺔ اﻳﻀﺎ ان ﻧﺴ  
اﻟﻤﺎﻳﺴﺘﻮﻣﺎ ﺑﻌﺪ ﺗﻜﺮار اﺑﺤﺎث ﺣﻀﺮوا اﻟﻲ ﻣﺮآﺰ% 7.26ﺑﺎﻟﻤﺮض ﺑﺤﻮاﻟﻲ ﺳﻨﺔ آﺎﻣﻠﺔ وﻧﺴﺒﺔ 
ﻳﻌﺎﻧﻮن ﻣﻦ % 8.13 وان ﻧﺴﺒﺔ –آﺎﻧﻮا ﻳﻌﺎﻧﻮن ﻣﻦ ورم واﻓﺮاز ﺣﺒﻴﺒﻲ % 4.56اﻻﺻﺎﺑﺔ وﻧﺴﺒﺔ 
ﻟﻢ ﻳﺬآﺮوا ﺳﺎﺑﻖ % 9.06 وﻧﺴﺒﺔ . ﻟﺪﻳﻬﻢ اﺻﺎﺑﺎت ﻣﺎﻳﺴﺘﻮﻣﺎ ﺑﺎﺳﺮهﻢ % 1.93اﺻﺎﺑﺔ ﺑﺎﻟﻌﻈﻢ وﻧﺴﺒﺔ 
  .اﺻﺎﺑﺔ ﺑﺎﻟﻘﺪم 
ﻣﻦ اﻟﻤﺮﺿﻲ واﺳﺮهﻢ ﻟﺪﻳﻬﻢ ﺑﻌﺾ اﻟﻤﻌﻠﻮﻣﺎت ﻋﻦ اﻟﻤﺮض وآﻞ % 4.68هﻨﺎﻟﻚ ﻧﺴﺒﺔ   
ﻳﻌﺘﻘﺪون ان % 5.56هﻨﺎﻟﻚ ﻧﺴﺒﺔ .  ﺘﻘﻮا هﺬﻩ اﻟﻤﻌﻠﻮﻣﺎت ﻣﻦ اﻻﻃﺒﺎء اﻟﻤﻌﺎﻟﺠﻴﻦ ﺳهﺆﻻء اﻟﻤﺮﺿﻲ ا
ﺘﺨﺪﻣﻮا ﻋﺪة اﻧﻮاع ﻣﻦ اﺳ% 7.23ﻋﻼج اﻟﻤﺎﻳﺴﺘﻮﻣﺎ ﺑﺎهﻆ اﻟﺜﻤﻦ وﻣﻜﻠﻒ ﺟﺪا وﻣﻦ ﺑﻴﻬﻢ ﻧﺴﺒﺔ 
  .اﻟﻌﻼﺟﺎت اﻟﺒﻠﺪﻳﺔ 
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Chapter One 
 
1- INTRODUCTION AND LITERATURE REVIEW 
 
 Mycetoma is a major health problem in tropical and 
subtropical areas and it is reported from different part of the 
globe, but it is dreadfully neglected by both society medical and 
health communities across the world(1). 
 There is very little or insufficient studies done about 
mycetoma in children both  in Sudan and the globe found in the 
literatures and in the internet . 
 It is an important health problem affecting the poor in 
Sudan and many other developing countries.  It is one of the 
neglected diseases and it is only recently that many of the 
previously unknown factors about the disease have been 
addressed seriously using newer techniques particularly in 
immunology, molecular biology, electron microscopy, 
ultrasonography and animal experimentation.  This has 
resulted in better understanding of this challenging problem 
and consequently better management of patients(1). 
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Mycetoma is a chronic granulomatous, progressive 
inflammatory disease that involves the subcutaneous tissue 
after a traumatic inoculation of the causative organism.  It may 
be caused by true fungi (eumycetes) or by higher bacteria 
(actinomycetes) and therefore it is classified into eumycetoma 
and actinomycetoma respectively(2).  The characteristic triad of 
a painless subcutaneous mass, sinuses and the discharge of 
grains are pathogonomonic of mycetoma.   The lesion usually 
presents as a slowly progressive painless swelling at the site of 
a previous trauma and gradually increases in size.  It may 
spread to involve the skin and deep structure resulting in 
destruction of bone, deformity and loss of function with serious 
social and economic implications.  The disease is progressive, 
the treatment may last for a long time, and some may develop 
recurrence after adequate treatment.  The pathogens are found 
in the soil of the endemic areas as saprophytes and are 
introduced into the subcutaneous tissue by trauma (3).  
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1.1 Historical Background: 
 Mycetoma was probably known by the ancient Indian 
writers as padavalmita.  The earliest medical description of 
mycetoma appears to be in the doctoral thesis of the German 
physician and traveler (4). 
Mycetoma was also named St. Thomas’s bean as St. 
Thomas is said to have spent his last days in southern India (4).  
The first case of mycetoma infection has been reported 
from Medras town in India in 1812 and hence the name madura 
(5). 
Mycetoma was recorded by French missionaries in 
Ponchichery in India in 1812 where it was known there since 
1710.  Gill of the Madurrai Dispensary in Madras province, in 
southern India is frequently mistakenly quoted as the first to 
report on mycetoma in the medical literature.  He described this 
condition as a foot covered with large fungoid excrescence 
discharging an offensive ichorous fluid (5). 
Godfrey in 1846 reported four patients with lumpy 
swellings of the foot in two of them there was bone destruction  
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and in the other two, cyst filled with melanotic matter were 
recorded.  He named this condition “morbus tuberculosis pedis" 
(6).  
Celebrook (1848) introduced for the first time the term 
madura foot (7). 
Billingall in 1855 described the microscopic details of the 
disease, with respect to the bony changes and tissue destruction 
in mycetoma (8). 
 Eyre (1859) reported 40 patients treated during 1844-
1848.  He drew attention to the small grains seen within the 
lesion and that the amputation was the treatment of  choice (9). 
 Minas (1860) reported mycetoma in hand and noted the 
prevalence of black grain mycetoma in his patients (10). 
 Van Dyke center (1860) after isolation of the fungus, 
stressed the fungal parasitic origin of the disease and he was 
the first who coined the term mycetoma.  He also described 2 
varieties of mycetoma, the melanoid type with black granules 
and the orchoid one with white granules.  He suggested that, 
the latter variety is produced by a different species of fungi (11). 
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 Dymock (1881) reported for the first time on local 
recurrence after surgery in a patient with yellow mycetoma(12). 
 Bocarro (1894) distinguish between the black and white 
mycetoma each of which had been caused by different 
organism(13). 
 Boyce and Surveyor (1894) were able to describe the host 
tissue reaction to the organism (14).  
 Gremy and Vincent (1894) reported the first African case 
of mycetoma in Algeria and probably the patient contracted the 
infection when he was in Tunisia, and they isolated the 
anaerobic actinomycete (15). 
 Brumpt (1906) listed the causal agents of mycetoma (16). 
 Laveran (1906) described the micrococcus pelletierii (17). 
 Pinoy (1913) was the first to study actinomycotic agents 
and classified mycetoma organism into 2 main groups; the 
actinomycete   and the true fungi (18). 
 
1.2 Mycetoma in Sudan: 
 Sudan seems to be the mycetoma homeland.  The disease 
had been known since the time of Mahdeya (1885-1899) or 
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before, it is commonly known by the name  “Nebit” meaning 
growth(15).  However Belfur published the first documented case 
in 1904(19).  He noted that the disease was common amongst 
Northern Sudanese, that the foot was affected most and that 
the commonest type was the black grain variety (19).  The first 
case from southern Sudan was reported from Bor in upper Nile 
by Weyon in 1908 (20). 
 Chalmers and Archibald gave quite an elaborative and 
specific definition of mycetoma, and they introduced the term 
maduramycoses and actinomyces, proceeded afterwards to 
classify the mycetoma into maduromycetoma the grain of which 
are composed of large segmented mycelia and actinomycetoma 
with grains composed of fine non-segmented filaments (21). 
 In 1931 Grantham Hill made a detailed clinical study of 
184 patient, out of which 64% were of the black variety and 36% 
were yellow, the yellow type being actinomycotic and the black 
is maduromycotic.  He thought that the actinomycotic type was 
more virulent, infiltrates gradually and once it  penetrate the 
periosteum it disseminates rapidly in bone while the black type 
forms a localized usually subcutaneous tumour.  He thought 
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that the best routine treatment was surgical, and that the key 
to success lies in early recognition and complete removal.  He 
was aware that amputation will defer patients from attending 
hospital and therefore encourage early detection.  In his study 
he had 77% of patients treated by local removal and 23% by 
amputation.  He supported the common belief that Nebit, 
usually follows a thorn prick by saying that in 30% of his 
patient with mycetoma of less than six month duration, thorns 
were actually found embedded in the growth after removal at 
operation (18).  
 Abbott in 1954 noted that trophic and neurological 
changes were absent in mycetoma patients.  He also noted that 
the tendon and nerve lay unaffected in the middle of damage 
tissue (22). 
 
1.3 Epidemiology: 
 Mycetoma infection is worldwide distributed but more 
commonly in tropical and subtropical countries of Africa, the 
middle East, part of Asia and south America(23).  These areas 
lies between 15oS – 30o N of the equator.  These areas known as 
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mycetoma belt which includes Sudan, Senegal, India, Yemen, 
Mexico, Venezuela, Columbia Argentina and others.  In Africa, 
mycetoma is most frequently seen in Sudan, Senegal, 
Mauritania, Kenya, Niger, Nigeria, Ethiopia, Chad, Cameron 
Djibouti and Somalia (23).  However many cases have been 
reported in 10 temperate region (23).  The area where mycetoma 
is endemic share the factor that they have a short rainy season 
of 3-4 month, temperature of 30o – 37o C and hot, dry season of 
8-9 month with temperature of 45o C and humidity of 12-
18%(23).  This weather favors the growth of Acacia and other 
thorny trees.  The thorns are possibly parasitized by the causal 
organism, a prick by these thorn will introduce the organism 
directly into the body.  The disease is common among rural 
people who come in direct contact with the soil such as farmers 
and those bare footed in endemic area(24). 
 The prevalence of one type or another depends on many 
factors.  The climatic factor is an important one, type of soil and 
demographic feature of susceptible population(25).  M. 
mycetomatis is common in tropical areas of Africa and India 
(rainy area), whereas S. somaliensis is predominant in middle 
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east, central and west Africa(26).  It is sometimes seen in rainy 
areas in Mexico(27).  In the relatively humid area A. pelletieri is 
common and in temperate region Nocordia species accounts for 
the main cause of actinomycetoma infection(28). 
 Few cases of eumycetoma  have been reported in upper 
Egypt(29) and were all caused by M. mycetomatis. 
 A. madurae account for 70% of cases in Tunisia(23) 
Mycetoma is rare in Tunisia, and only observed sporadically, for 
this reason the diagnosis is usually late with severe 
functional,psychological and socioeconomic   consequences(30). 
 130cases of mycetoma were reported in Senegali  
patients between 1983 - 2000 ,70% were due to actinomyctoma 
and 30% were due to eumycetoma(31). 
 The disease is endemic in the northern areas of West 
Africa.  It is more common in male, rural inhabitants and the 
age group was  between 20 – 40 years of age.  The main 
etiological agents are S. somaliensis, A. pelletier, A. madurae, 
M. mycetomatis and Leptosphaeria species.  In the west 
Sahelian belt actinomycetoma is more frequent than 
eumycetoma except in Mauritania.  Ultrasonographic technique 
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appears to be very useful in medical centres where no 
mycological test can be done(32). 
 In Africa mycetoma is more frequent, in males and 
affects the age group between the second and fourth decades(33). 
 The Pasteur Institute studied 103 mycetoma patients in 
Somalia between 1959 and 1964.  grains were seen in 94 of 
them and this, added to cultural features, allowed the diagnosis 
of 60 pathogens as follows:  44 Madurella mycetomatis, 1 
Leptosphaeria senegalensis, 7 Pyrenochaeta remeroi (or 
Madurella grisea), 3 Allescheria boydii, 1 Fusarium species, 3 
Neotestudina (Zopfia) rosatii, and 1 unidentified; 34 were 
actinomycetes: 24 Streptomyces somaliensis, 4 Actinomadura 
madurae, 3 A. pelletieri and 3 Nocardia species.  The patients 
delayed too long in consulting their doctors and health 
education is vital if amputations are to be avoided.  The 
geographical distribution is related to climate and fungal 
species.  In central Somalia the association of M. mycetomatis 
and S. somaliensis, organisms characteristic of desert 
conditions, was found; white grain mycetomata and those 
caused by Nocardia species occurred in more humid areas.  The 
study revealed 2 new fungi.  One, obtained in culture was called 
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Neotestudina (Zopfia) rosatii.  The 3 patients affected, lived in 
Mudugh (2 in El Bur).  The other fungus was not identified.  It 
also was recovered from El Bur and one with similar 
microscopic characters has been seen in Chad .  Both fungi are 
desert species(34). 
 In Saudia Arabia the clinical and microbiological 
features of 31 cases of mycetoma seen in 8 years at a Riyadh 
hospital were described.  Eighteen were due to Streptomyces 
somaliensis, 10 to Madurella mycetomatis and one each to 
Actinomadura madurae, Nocradia asteroids, and an 
unidentified species of Cladosporium.  No immune defects were 
detected in the patients.  Eleven had osteolytic lesions and 17 
required surgery.  Only seven patients were cured.  
Streptomyces infections were seen from all parts of Saudi 
Arabia outside the Rub Al Khali, but Madurella occurred 
mostly in highland regions where rainfall was higher(35). 
 Mycetoma is wide spread in Yemen but has not been 
fully documented.  The majority of infections were due to 
eumycetes(36). 
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 In west Bengal between 1981-2000, 264 cases of 
mycetoma were diagnosed clinically and microbiologically at 
Calcutta school of tropical medicine.   The study revealed that 
the ratio of actinomycetoma and eumycetoma was 197 : 67, the 
male to female ratio was 183:81.  Pricking was the most 
common injury associated with eumycetoma.  The peak age of 
onset was between 16 and 25 years in 114 cases and the earlist 
age of onset was 6 years(37). 
 In India they reported a case of mycetoma of the sole of 
the foot in a 10 years old child caused by N. brasiliensis(38) and 
treated successfully with trimethoprim – sulphamethozole, 
dapsone and rifampicin. 
 In the United States, actinomycetoma caused by 
Actinomadura madurae occurred in an Indian factory worker 
(39).  It is rare there and only one case of black grain infection 
has been reported in North America(40). 
 In south and central America N. brasilliensis is the 
commonest cause of mycetoma(39).  It accounts for 85.6% of 
actinomycetoma cases in Mexico followed by A. madurae, S. 
somaliensis and A. pelletieri(25).  A case of actinomycotic by N. 
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asteroids, a rare etiologic agent of infection   has been reported 
in Brazil (41). 
 Biagini and his collegues had reported 39 cases of 
mycetoma  mainly caused by  N.brasiliansis among Argentinian 
farmers(42] 
 In central Europe, the disease is rare but cases have been 
reported from Italy and Romania.  It is caused by both M. 
mycetomatis and A. madurae(25). 
 In Mexico mycetoma prevails in males and they are more 
frequent between16-45 years of age among rural workers.  
Actinomycetomas are the most frequent(27).  It preferentially 
affect the lower limb. 
 Few cases have been reported from each of the United 
State(43), Ceylon and Turkey(44,45). 
 In Sudan, males are affected more than females in the 
ratio  of 5 : 1(22).  This is a genuine sex difference and is not 
related to the greater outdoors activities of males because in 
certain area in Sudan, males and females go out to work in the 
fields side by side.  The disease is commoner between age group 
20-40 years, this being the earning group, but no age group is 
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immune.  In fact cases have been seen in chidlren4-5 years 
old(46). 
1.4 Etiology: 
 True fungi (eumycetes) or aerobic bacteria 
(actinomycetes), which are higher class of filamentous bacteria, 
can cause mycetoma.  Botryomycosis is a type of mycetoma 
infection caused by bacteria(47).  In endemic area the causative 
agents have been isolated from soil as saprophytes (48,49). 
 Eighteen species of eumycetes and actinomycetes have 
been isolated from cases all over the worlds(46). 
 Rarely, A. flavus can cause eumycetoma and a case of 
green grain eumycetoma due to A. flavus has been reported in 
Sudan(50) and another case caused by A. israeli. 
 In Sudan M. mycetomatis account for 71.4% of all 
mycetoma cases.  S. somaliensis for 18% A. madurae 5.3%, A. 
pelletieri 2.7%(46). 
 Fungi that cause eumycetoma include M. mycetomatis, 
M. grisea, Leptosphoria senegaliensis.  Pyrenochaeta romeroi.  
Phialophore jenselmii, Curvularia lunata, peterilidium boydii, 
Aspergillus nidulans.  A. flavus, Neotestudina rosatii and N. 
flavus.  Actinomycetoma is mainly caused by S. somaliensis, A. 
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madurae, A. pelletieri and Nocardia species, which include N. 
brasiliensis.  N. asteroids and N. otilidiscavarium (26). 
 Actinomycetoma is commoner than eumycetoma in Niger 
where the disease prevails.  In the North desert zone, the 
disease is predominantly caused by S. somaliensis, whereas in 
the southern part it is caused by A. pelletieri, followed by N. 
brasiliensis and A. madurae(51). 
 
1.5 Route of infection: 
 Mycetoma is a non-contagious disease.  The grains of the 
causative organism are usually found in the soil as saprophytes 
that when the rain moistens them they form conidia and other 
infectious forms.  These forms can be introduced to the 
subcutaneous tissue by a trauma of skin by thorns, stones, or 
other sharp objects (24).  Nevertheless, many patients gave no 
history of previous trauma (2).  The disease can occur naturally 
in a number of animal including goats(52),  horses(53), donkeys(54), 
dogs(55) and cats(56).  So far man to man or animal to man 
transmission is not known. 
Incubation period: 
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 The incubation period of mycetoma is unknown because 
of the difficulty in establishing the time of initial infection.  
However, in experimental animals the granuloma was noted 
after three weeks from the inoculation of the organism (57). 
 
1.6 Sites of infection: 
 Mycetoma is commonly seen in those parts, which are in 
contact with soil during walking sitting or lying down.  The foot 
is the commonest site of mycetoma; it accounts for 70%.  
Usually the dorsal aspect is more affected than the forefoot and 
for unexplained reasons the left foot is more affected than the 
right foot (24).  The hand is the next commonest site (12%).  
However, other parts of the body are involved such as knee, 
arm, leg, head, neck, thigh, perineum and cervical (58). 
 Unusual sites: include scapulo-thoracic including 
scapular, axillary and chest, kidney, abdominal wall, inguinal, 
buttock and the mastoid bone (59-61). 
 Cranial mycetoma was proved to be fatal and difficult to 
treat(62). 
1.7 Mycetoma radiology: 
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 Mycetoma is known as a destructive osteolytic infectious 
disease and it produces many radiological changes.  These 
changes are seen more in actinomyctoma infection and being 
less in eumycetoma infection (63).  Three different stages of the 
disease can be distinguished radiologically (63). 
 Soft tissue granuloma:  It appears as a dense shadow 
or scattered multiple granuloma.   
 Involvement of the cortex:  many changes are seen 
with periosteal reaction. 
 Involvement of the whole bone:  At this stage multiple 
cavities are seen in the bone. 
 The size and number of cavities are useful in 
distinguishing between eumycetoma and actinomyctoma.  
Eumycetoma produces large and few, with defined margin 
cavities, while cavities seen in actinomyctoma are smaller in 
size, numerous and have no definite margin (64). 
 The difference in size of cavities is due to the difference 
in the grain’s size and the difference in number is due to the 
aggressiveness of the causative organism (2).  These cavities are 
filled with grains which gives bone support, hence fracture is 
not common in mycetoma (2).  Periosteal bone erosion from 
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outside without cavitations is often seen with the involvement 
of the metatarsal bones and less frequently seen in the 
calcaneum (63). 
 Osteomyelitis if present is readily detected.  Osteoporosis 
distal to the affected part is common and this may be due to the 
disease atrophy or due to the compression of the bone and its 
blood supply by the granuloma (2). 
 Mycetoma has a characteristic ultrasonographic 
appearance; in eumycetoma the grains produce numerous, 
sharp hyper-reflective echoes and there are single or multiple 
thick walled cavities.  In actinomyctoma, the findings are 
similar but the hyper-reflective echoes are fine, closely 
aggregated and commonly settle at the bottom of the cavities (2). 
 CT was used for the diagnosis of mycetoma, the 
sensitivity was found to be 62% and the specifity 94%, and the 
positive predictive values were 93%, while the negative values 
were 66% (65). 
1.8 Differential diagnosis: 
 It is worth mentioning that any swelling in endemic 
areas has to be considered as mycetoma until it is verified (2).  
The differential diagnosis of mycetoma includes many of soft 
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tissue tumors as Kaposi sarcoma, neurofibroma, malignant 
melanoma and fibrolipoma (23). 
 The presence of bone destruction in the absence of 
sinuses tends to favour the possibility of tuberculosis (66).  The 
radiological features of advanced mycetoma may be comparable 
to those of osteogenic sarcoma (2).  Also osseous mycetoma is to 
be differentiated from chronic osteomyelitis, osteoclastoma, and 
bone cysts and from syphilitic osteitis (66). 
1.9 Laboratory diagnosis: 
 Marco and microscopic examination:  pus exudates, 
biopsy or tissue material can be examined for the presence of 
grains.  The morphology, texture, colour and shape may 
indicate the causative organism.  As the grains may not show 
typical colours especially among actinomycetes, other 
examinations are always necessary for definitive diagnosis(67). 
 Grains are crushed between two slides,  few drops of 10% 
potassium hydroxide are added, covered with a coverglass and 
examined microscopically.  Thus one can differentiate between 
actinomycetes and eumycetes as eumycetes have broad mycelia 
strands that may have large swollen cells (15 µm or more), 
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while actinomycetes have fine filaments, which are 0.5 to  1 µm 
in diameter (68). 
 Albert and Giemsa stains can also be used for staining 
and examining actinomycetes (68). 
 Culture:  For culture, grains are better obtained from 
deeper sites, as the grains extruded through sinuses are often 
dead and can be contaminated by secondary bacterial infection.  
Biopsy or tissue materials taken during surgery are ideal for 
culture (57). 
 Actinomycotic grains are washed in normal saline, if 
large are crushed and then cultured on blood agar, brain heart 
infusion or Lowenstein – Jensen medium and incubated at 37oC 
for two to three weeks.  Then, identification of type of 
actinomycetes depends on macroscopic morphology, 
characteristic colony morphology, physiological characteristics 
or reaction to certain chemical reagents (67). 
 Eumycetoma grains are washed in normal saline 
containing an antibiotic such as chloramphenicol, to avoid 
bacterial contamination, and then cultured on blood agar or 
sabouraudd dextrose agar and incubated at 37oC for six to eight 
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weeks,   then identified by observation of rate of growth, colony 
morphology, production of conidia and assimilation patterns (67). 
 Grain morphology is so variable that it is not always an 
appropriate method to distinguish the type of organism.  
Nevertheless, some grains have definite morphology such as S. 
somaliensis, M. mycetomatis and A. pelletieri. 
 Culture of surgical biopsy from mycetoma lesion is 
essential for definitive diagnosis of mycetoma and presumptive 
identification of the possible causative agents by the 
appearance of characteristic grains.  Nevertheless, culture is 
time consuming, prone to secondary bacterial contamination 
therefore needs deep surgical biopsy under general anaesthesia 
and not cost-effective in endemic areas (67). 
 Sero-diagnosis:  serology has great advantages over 
culture and hisopathology, as both required surgical biopsy, but 
it has the problem of lacking the standardized and well-
characterized antigens and the cross reactivity between the 
different actinomycete antigen (24).  Nevertheless, serology can 
be used in identification and classification of the causative 
organism, which is essential for the treatment and follow-up (24). 
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1.10 Pathology of mycetoma: 
 Like any chronic inflammation, mycetoma forms a 
granuloma.  One or all the three types of reaction can be found 
in the same mycetoma lesion(68). 
 In type I reaction, there is a zone of neutrophils in the 
vicinity of the grain.  Some histiocytes may also be seen among 
the neutrophils but they are numerous outside the neutrophil 
zone.  Surrounding the neutrophil/histiocyte zone are abundant 
capillaries, which are sometimes surrounded by a layer of 
fibrin.  Lymphocytes, plasma cells, fibroblasts and some 
macrophages are usually seen.  They increase in number 
towards the periphery of the lesion (68). 
 In type II reaction, most neutrophils mostly disappear 
and are replaced by histiocytes and multinucleated giant cells.  
Some giant cell in M. mycetomatis infection contain fragments 
of grain or pigmented cement substance without any hyphae.  
In actinomyctoma they contain viable actinomycetes which are 
believed to contribute to the spread of the organism in the 
tissue and the regional lymphnodes (62).  The grains at this stage 
are usually small and fragmented by neutrophils.  This 
fragmentation is severe in M. mycetomatis infection and less in 
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actinomycete infection.  This may be due to the more compact 
and hard grains of actinomycetes (68). 
 In type III reaction, M. mycetomatis grains mostly or 
completely disappear leaving compact epithelioid granuloma 
with or without Langerhan’s giant cells.  This pure epithelioid 
granuloma is not seen in actinomycete infection (68). 
 In spite of the invasive nature of actinomycetes, the 
grains neither invade tendons nor nerves.  In the last stages of 
mycetoma infection, bone are frequently involved(2). 
 Blood vessels in mycetoma show hypertrophy of muscles 
and have narrowed lumen containing grain fragments.  These 
may explain the rare haematogenous spread to distant site (2). 
 Lymph-nodes are occasionally enlarged in mycetoma 
patients (69).  They show follicular and/or sinus cell hyperplasia, 
intense plasma cell infiltration in the medulla cords and some 
of the plasma cells contain Rossel bodies.  Melanin pigment and 
haemosiderin are found in histiocytes.  However, sometimes 
especially in actinomycete infection, grains are found in the 
nodes.  In early cases only grains are found scattered in the 
node without any other change.  Later, the node shows 
hyperplasia and deposits of melanin and haemosiderin.  
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Neutrophils polymorphs, histiocytes and giant cells were found.  
In advanced cases vascular fibrous tissues were seen and in 
more advanced cases no lymphoid tissue could be seen(69).   
These changes are of intense antigenic stimulation, partly due 
to the accompanying secondary bacterial infection and almost 
due to the fungal antigen stimulation. 
1.11 Mycetoma immunology: 
 Antibodies against mycetoma organisms usually develop 
after infection.  All three types of antibodies (IgA, IgG and IgM) 
are produced and they have been demonstrated by means of 
immunodiffusion, counterimmunoelectrophoresis (CIE), 
complement fixation (CF) and ELISA (70,71). CIE is regularly 
used for the diagnosis of mycetoma, identification of the 
individual organism and for following-up patients on medical 
treatment as they decrease with recovery and disappear with 
cure (72). 
 Old  study done in 1930 found that IgA increases 
irrespective of the causative agent and the extent of tissue 
involved in the lesion, while IgG and IgM show poor response in 
cases with extension of lesion to bone (73). 
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 PCR can also be used for identification of M. 
mycetomatis(74). 
 
Microscopic appearance of Madurella mycetomatis: 
 M. mycetomatis is the main cause of mycetoma infection 
in Sudan.  This organism has black, hard  and big grains with 
size ranging between 200 to 900 µm.   the grains may be 
rounded, oval, bilobated or trilobated in shape and they may 
aggregate to form a mass of 2 to 4 mm in size. 
 The main morphological types of grains are identified; 
the filamentous type, which is the commonest one; the other is 
the vesicular type.  Both types of grains can be found in the 
same lesion.  Moreover, grains, which are partially vesicular 
and partially filamentous, are commonly seen. 
 Ultrastructurally, the grains are found encased in dark 
brown cement, which is a unique feature of M. mycetomatis 
grains (61).  As no individual cell component was visibly 
responsible of this dark colour, nor was any constant pigment 
particle identified, so the source of this pigment was thought to 
be the cell cytoplasm.  Histologically it resembles melanin or it 
may be a fungus product (28).  The hyphae are septate, the 
 26
cytoplasm may be densely ribosomal or disorganized.  Nuclei 
and mitochondria and other organelles are not usually seen.  
Intra-hyphal growth is sometimes seen.  The hyphal wall is 
often markedly thickened, surrounded by homogenous matrix of 
electron dense area and a layer of cement outside it (28). 
 Study of the ultrastructural host tissue reaction shows 
neutrophils adherent to the grain.  The cytoplasm of the 
neutrophils is stretched over the grain and the neutrophil 
granules are concentrated in the part of the cytoplasm adjacent 
to the grain.  This is an immune adherence mediated by 
immunoglobulins and is an example of antibody dependent cell 
mediated cytotoxicity (28). 
  
 1.12 Treatment of mycetoma: 
 Treatment of M. mycetomatis infection is difficult.  Rate 
of recurrence after surgery is high.  Therefore, combination of 
medical treatment with surgery is important.  Although, the 
grains were sensitive to ketoconazole in the in vitro test (62).  In 
vivo the recurrent rate is high.  It is thought that many 
ultrastructure features account for the difficulty of treating the 
M. mycetomatis infection with antifungal drugs.  The 
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homogenous matrix of electron dense, the layer of the cement 
that surround the grains and the maximum thickening of the 
cell wall at the periphery of the grains, are thought to prevent 
penetration of drugs and so increase the recurrence rate (75,28). 
In the past, the treatment of mycetoma in Sudan was practiced 
by the native practitioner by cautery and/or amputation (18).  In 
a small survey done in Sudan it was found that many types of 
native medicines were used. 
 In 1931, the senior surgeon at Khartoum Hospital 
doubted the value of medical treatment by various drugs 
suggested up to that date.  He thought that the best treatment 
was surgical excision especially if it was in the early stages 
when complete removal could be done.  However, he was faced 
by a high rate of recurrence due to the difficulty of adequate 
removal (22).  Later on, in 1955 in vitro trials with different 
antibiotics such as chloramphenicol, oxytetracycline, 
carbamycin and polymyxin-B against M. mycetomatis  were 
carried out.  The organism was found to be resistant to all of 
them (76). 
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 Treatment of actinomycetes has been tried successfully 
with a combination of streptomycin in a dose of 14 mg/kg daily 
for the first month and then on alternate days combined with 
1.5 mg/kg morning and evening of dapsone.  14 mg/kg twice a 
day of cotrimoxazole, 7.5 mg/kg twice weekly of sulphadoxine-
pyrimethamine or 4.3 mg/kg body weight of rifampicin twice 
daily (68).  This regimen is now accepted globally and becomes 
the standard regimen for treatment of actinomycetoma.  
Recently, for patients resistant to these drugs, amikacin was 
used alone with 95% cure rate or in combination with 
cefotaxime, 1 g every 8 hours and amikacin, 500mg  every 12 
hours in two cycles.   Surgery in actinomycetoma infection  is  
not preferred as it is thought to facilitate the grains spread 
through lymphatics system to other parts and also because its 
lesion usually has an ill-defined margin (2). 
 Eumycetoma treatment has the drawback problem of 
recurrence.  Therefore, medical treatment after surgery is 
suggested to minimize the recurrence.  Ketoconazole in two 
divided doses has been tried for the treatment of M. 
mycetomatis infection (77).  A combination of griseofulvin three 
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times a day and procaine peinicillin given intramuscularly was 
used as another regimen for the treatment of eumycetoma but 
with little success.  Nevertheless, the problem of recurrence or 
incomplete cure especially in the case of massive lesions is still 
an obstacle.  Hence, a different treatment strategy has been 
adopted.  This is by giving the patient a drug for a short time, a 
debulking or complete removal of the lesion with bone curettage 
is recommended, surgery should be performed under a bloodless 
field, using tourniquet, and under general anaesthesia and then 
this is followed by another period of drug treatment for six to 
twelve months .  This course of treatment has been found to be 
the best to minimize the recurrence rate, but even though it is 
still high (2). 
 Recently the newer antifungal, itraconazole has been 
used to treat different types of eumycetoma including M. 
mycetomatis infection (78). 
 In Senegal they reported 90 cases of actinomycetoma 
occurring in male adult patients coming mainly from central 
Senegal.  The lesion localized on the foot in 50% of cases and 
other part of the body for the other half.  Bone involvement was 
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observed  in 55% of cases.  83% of patients were cured after one 
year treatment of sulphamethexazole orally.  2 patients died of 
visceral involvement (79). 
 Mycetoma is uncommon in children.  Retrospective study 
was conducted in children less than 15 years of age during 25 
years period.  Total number of patient was 334; 15 of which 
(4.5%) were in patients 15 years of age and younger.  Age range 
between 6-15 years and the mean age was (11.24); 12 were male 
and 3 females.  The main site was the foot in 10  patients 
(66.6%).  Aetiologies include 13 actinomycetoma, 2 eumycetoma.  
Eatiologic agents were Nocardia brasiliensis in 12 cases.  
Nocardia asteroids(1) and  Madurella mycetomatis in 2.  11 of 13 
active treatment with trimethoprim – sulphamethoxazole puls 
diaminodiphenyl sulphone were cured.  The 2 failure were 
successfully treated with amoxicillin/clavulenate.  One of 
eumycetoma was cured with itraconazole therapy, whereas 
other various treatment eventuating in surgical amputation(80). 
 Treatment  with cotrimoxazole in two immunocompetent 
children, exhibit two clinical form of cutaneous nocardiosis 
(mycetoma)  led to complete healing     (81). 
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Study was done in mexico to determine the incidence and 
epidemiology of mycetoma.The data was collected from 2105 
cases through about 30years (1956-1985).Sex distribution was 
76.1%in males and 23%in females.35%of cases between 16-30 
years of age . Lower limb was affected in 64.1%,upper limb in 
13.6% and the trunk in 17.4% .The causative agent was 
actinomycetes in 97.8% and eumycetes in 2.2%(82)   
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Justifications 
• Mycetoma is a common   disease in Sudan  
•   It has high morbidity. 
• It affects  all age groups 
• It is complications are preventable disease. 
• No study had been done specificaly in children. 
• No educational program had been carried out about 
mycetoma in Sudan. 
 
Objectives 
 
To study: 
• The clinical presentation of mycetoma in children.  
• The knowledge, attitudes and practice towards the 
disease. 
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2-  Methodology 
 
2.1 Study Design:   
Prospective -Descriptive – Hospital based study. 
 
2.2 Study Area:   
Mycetoma research centre at Soba University Hospital – 
Khartoum - Sudan. 
 
2.3 Study Period:   
From May 2006 to September 2006. 
 
2.4 Study Population:   
2.4.1. Study sample:  
All children attending mycetoma referral clinic who are 
18 years and less during the study period. 
 
2.4.2. Sample size:  
Total coverage sample for all children who attended  
mycetoma during the study period  
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2.5 Inclusion criteria:   
Children < 18 years with mycetoma. 
 
2.6  Exclusion criteria:   
- Undiagnosed patient. 
- Refusal of patient or their parent to be enrolled in 
the study. 
 
2.7.Methods: 
2.7.1.Study tools :  
• Questionnaire. 
• History clinical examination and preformed 
investigations. 
• Biopsy and FNA results  
 
  2.7.2. Study technique: 
• Questionnaire for data collection containing 
personal data clinical history,  general  and 
local examinations.   
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• The child and his/her caretaker was 
interviewed through the questionnaire by the 
author. 
• A through clinical examinations  were 
conducted for each child. 
• Relevant investigations done to those children 
were recorded including CBC, liver function 
tests ,  X-rays and results of FNA and 
histopathology. 
• FNA and histopathology were done by 
consultant histopathologist and the findings 
were recorded.    
 
2.8. Ethical approval:   
? Written approval will be obtained from hospital 
administrations. 
? Written approval will be obtained from the director of 
mycetoma research centre. 
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? Verbal consent will be taken from the patients and their 
parents. 
?  
2.9 Statistics:   
The data was entered and analyzed using the SPSS 
(Statistical Package for Social Sciences) computer program.  
Cross tabulation between variable was done.  The X2 test was 
used with p value at 95% confidence level was used as the test 
of significant, probability value of < 0.05 was considered 
significant. 
2.10. Research team:  
• Researcher. 
• Histopathologist. 
• Statistician.  
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Chapter Three 
3- Results 
The study groups were all children 18 years of age and less, 
who attended the mycetoma referred clinic at Soba University 
Hospital ;and had been diagnosed as cases of mycetoma.  The study 
groups were 110 patients during the study period, all of them came 
from rural areas from different parts of the Sudan, and all of them 
were of low socio-economic class.  The gender distribution were 74% 
in males and 26% were females.  (Figure 1)  
Distribution of patients according to age was 54.5% between 
15-18 years, 39.1% between 10-14 years and 6.4% from 5-9 years of 
age.  The youngest age of presentation in the study group was 5 years 
of age. (Figure 2)  
Distribution of patients according to residence was 91% from 
central part of Sudan mainly from Gezeira and Sinnar State, 
respectively, 7.2% from the west, 0.9% from the east, 0.9% from the 
south and there was no patient from the North. (Figure 3) 
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The most commonly affected site was the lower limb (68%) 
and the left foot is more commonly affected than the right (44%).  The 
other 
affected site was the upper limb (5.8%),while the other part of the 
body e.g. scrotum, knee and leg constitute for 8.2% of the study 
group. (Figure 4) 
The majority of the study group presented after one year of 
infection (68.2%), 15.4% less than one year and 16.4% present after 5 
years of infection. (Figure 5) 
The majority presented to the centre after recurrence (62.7%) 
while these who had first presentation constitute for 37.3%. (Figure 6) 
65.4% of patient presented with both sinuses and mass, 17.3% 
presented with mass only and 17.3% with sinuses mainly. (Figure 7) 
The causative organism was mainly fungi (95.5%) and 
bacterial type in 4.5% of the study group.  (Figure 8) 
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The bone was affected in 31.8%, (Figure 9) and there is no 
relation between the age of the patient and bone involvement.  The 
difference was statistically not significant (P > 0.1). (Table 1) 
The bone was involved mostly in patients presented between 1-
5 years duration (57.1%), 8.6% in those who presented less than 1 
years of infection and 34.3% in those who present after 5 years of 
affection.  The difference was statistically significant (P < 0.01).  
(Table 2) 
There was family history in 39.1% of the study group . (Figure 
10) 
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Table 1:  Relation between age of the study group and bone 
involvement 
Age 
(Year) 
Bone infection None Total 
 n % n % n % 
5-9 3 8.6 4 5.3 7 6.5 
10-14 17 48.6 26 34.7 43 39.1 
> 15 15 42.8 45 60 60 54.5 
Total 35 100.0 75 100.0 110 100.0 
 
 
X2   =  2.85919 
P > 0.1 
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Table 2:  Relation between duration of illness and bone 
involvement 
Age 
(Year) 
Bone infection None Total 
 n % n % n % 
< 1  3 8.6 14 18.7 17 15.4 
1-5 20 57.1 55 73.3 75 68.2 
> 5 12 34.3 6 8 18 16.4 
Total 35 100.0 75 100.0 110 100.0 
 
 
X2   =  12.56732 
P < 0.01 
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The majority of the study group  60.9% gave no history of  
previous trauma. (Figure 11) 
85.7% of patient with bone involvement ha eumycetoma.  The 
relation between the causative organism and bone involvement was   
statistically significant (P < 0.01) (Table 3) 
The majority of fungal infection occurs in the central part of 
Sudan (94.3%).  The   difference was statistically significant (P < 
0.01). (Table 4) 
85.7% of patient with bone involvement had recurrent of 
mycetoma  .  The difference was statistically significant (P < 0.001). 
(Table 5) 
Most of the study group had some knowledge about the 
disease (86.4%) (Figure 12) . All  of them took their knowledge from 
their treating doctors .In this study   there is no relation between their 
knowledge and chronicity of the disease.  The difference was 
statistically significant (P < 0. 1). (Table 6) 
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Table 3: Relation between causative agent and bone 
involvement 
Agent 
 
Bone 
Involvement  
None Total 
 n % n % n % 
 Fungi 30 85.7 75 100 105 95.5 
Bacteria 5 14.3 0 0 5 4.5 
Total 35 100.0 75 100.0 110 100.0 
 
 
X2   =  11.22449 
P < 0.001 
 
 
 
 
 
 
 
 
 55
 
 
Table 4: Relation between causative agent and Residence 
of the study group 
Residence 
 
Fungi  Bacteria Total 
 n % n % n % 
 North 0 0 0 0 0 0 
South 0 0 1 20 1 0.9 
West 4 3.9 3 60 7 6.4 
East 1 0.9 0 0 1 0.9 
Central 100 95.2 1 20 101 91.8 
Total 105 100.0  5 100.0 110 100.0 
 
 
X2   =  47.670376 
P < 0.01 
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Table 5: Relation between chronicity of the disease and 
bone involvement 
Presentation 
 
Bone 
Involvement  
None Total 
 n % n % n % 
First 5 14.3 36 48 41 37.3 
Recurrent 30 85.7 39 52 69 62.7 
Total 35 100.0 75 100.0 110 100.0 
 
 
X2   =  11.601576 
P < 0.001 
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Table 6: Relation between the knowledge of patients and 
chronicity of the disease 
Knowledge 
 
First 
presentation 
Recurrent 
presentation 
Total 
 n % n % n % 
Yes 33 80.5 62 89.9 95 86.4 
No 8 19.5 7 10.1 15 13.6 
Total 41 100 69 100.0 110 100.0 
 
 
X2   =  1.9161814 
P > 0. 1 
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65.5% of patients thought that the treatment of mycetoma is 
very expensive, (Figure 13) and in spite of this 63.3% were adherent to 
treatment (Figure 14), and 76.9% of them had no bone involvement.  
The difference was statistically significant (P < 0.01). (Table 7) 
32.7% of the study group used traditional treatment before 
seeking medical advice (Figure 15). 
Treatment was in form of Mehaya  in 5.5%, labkha (24.5% and 
cautary in 0.9%. (Figure 16).  In this study there was no relation 
between uses of traditional treatment and bone involvement (P > 0.5). 
(Table 8) 
 
 
 
 
 
 
 
 
 
 
 
 
 60
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 61
 
 
 62
 
 
 
Table 7: Relation between adherence to treatment and 
bone involvement 
Treatment 
 
Bone Involvement  None Total 
 n % n % n % 
Adherent 15 42.8 50 66.7 65 59.1 
Not adherent 20 57.2 25 33.3 45 40.9 
Total 35 100.0 75 100.0 110 100.0 
 
 
X2   =  5.59625 
P < 0.01 
 
 
 
 
 
 
 63
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 64
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 65
 
 
Table 8: Relation between uses of traditional and bone 
involvement 
Uses of 
traditional 
treatment 
Bone 
Involvement  
None Total 
 n % n % n % 
Yes 11 31.4 25 33.3 36 32.7 
No 24 68.6 50 66.7 74 67.3 
Total 35 100.0 75 100.0 110 100.0 
 
 
X2   =  0.039325 
P > 0.5 
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Chapter Four 
 
4- DISCUSSION  
 
This is a prospective, descriptive, hospital  based study, 
conducted at Mycetoma Research Centre at Soba University 
Hospital . It aimed to study the clinical presentation of 
mycetoma in children less than eighteen years of age and their 
knowledge, attitude and practice towards the disease.  This 
study showed that mycetoma can occur in children similar to 
that reported by Gumaa S A(46)   who concluded that it does 
occur in children. Also agree with Develoux(32)  who reported 
Mycetoma in children . 
 The majority of cases were above ten year of age    ( 60.9  
%).  The male to female ratio is 3 :  1 which was in agree with 
study done in Mexico ( M : F = 4 : 1) (80).   
All patients were from rural areas from different parts of 
Sudan, but the central part had the highest percentage of 
patients which was in agreement with study done before in 
adults (46). 
The lower limb was affected in 87.5% of the study group 
while the other part of the body constitutes for  (12.5 %) which 
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was the same  with study done in Sudan in which  the foot was 
affected in (70%) of the study group(24) and Mexico where the 
foot was affected in 66.6% of the study group(80).  
 84.6% of patient presented after one year of infection, so 
there is delayed presentation to doctors as compared to study 
done in Somalia where they found that the patients had 
delayed presentation(34).  
 From those 62.7% presented with recurrent symptoms 
after treatment in other hospitals.  39.1% of the study group 
gave no history of previous trauma, in contrast to study done in 
west Bangal where they noticed that the pricking was the most 
common injury associated with eumycetes(37). 
39.1% of the study group gave history of mycetoma in 
their families who  were mainly rural inhabitants, this goes 
with study done in West Africa (34) and in Saudi Arabia (35).   
The majority of patients (65.5%) presented with both 
sinuses and masses. 
The majority of patients (73.6%) were diagnosed by 
histopathology after surgery. 
In 95.5% of the study group fungal mycetoma was the 
commonest type, in contrast to study done in West Bangal 
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where actinomycetoma predominated over eumycetoma (183 : 
81) (37),  and this also occured in Saudi Arabia (35), but it agrees 
with study done in Somalia (34) and Yemen (36)where fungal 
mycetoma predominate. 
31.8% of the study group had bone involvement and 2 
patients of them ended in amputation. 86.4% of the study group 
had some knowledge about the disease and all of them took 
these informations from their treating doctors.      
There were 32.7% of the study group who had some trial 
with traditional treatment, from which we noticed that there is 
no relation between uses of traditional treatment and affection 
of bone in the study group (P > 0.5), but there is strong 
correlation between the causative agent and affection of bone. 
Almost all cases due to bacterial type had bone involvement.  
While 85.7% of bone infection are caused by fungal mycetoma 
(P < 0.001). 
59.1% of the study group were adherent to treatment and 
used it regularly without interruption, but 42.9% of those with 
bone infection were among those adherent to treatment, so 
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there is strong relation between adherence to treatment and 
bone infection in the study group (P < 0.01). 
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Conclusion  
 
• Mycetoma commonly occurs in children especially these 
from rural area in Sudan. 
• It is less common in children less than 10 years of age and 
more common above 10 years of age. 
• Males predominate.  
• It affects the foot more frequently than the other parts of 
the body. 
• The majority had   late presentation. 
• Fungal mycetoma predominate the bacterial type (21:1). 
• The majority of patient were diagnosed after surgery by 
histopathology. 
• There was no obvious history of trauma in the majority of 
the study group. 
• The majority of patients were not aware about the 
disease; and those who had some knowledge, acquired it 
from the doctors and medical staff. So the multimedia had 
no role in the awareness of the population about the 
disease. 
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• The treatment of mycetoma is very expensive and there is 
no support from the Ministry of Health or hospstials nor 
the health insurance.  So some of the patient are not 
adherent to treatment and they end up by very serious 
complications. 
• There is no relation between the age of the patient and 
the affection of bone, but there is strong association 
between the long duration of the disease (more than one 
year) and the bone involvement which is very serious 
complication that will end up by amputation. 
• There is no association between the use of traditional 
treatment and bone involvement in the study group. 
• All cases of bacterial type have bone involvement 
irrespective of the duration. 
• Most of fungal mycetoma prevails in the central part of 
the Sudan, while the bacterial type prevails in the south 
and west. 
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Recommendations 
 
1.        To reduce the rate of mycetoma infection we need to raise 
the awareness of the people and medical staff  about the 
importance of early detection  . 
2.   Mycetoma control programmes are tobe incorporated  in the  
PHC programmes. 
3.      Availability of free treatment because the patients 
affected are from poor families .  
4.       Establishment of mycetoma centre in central region 
where most of the patient are coming .  
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Chapter Four 
 
5- DISCUSSION  
 
This is a prospective, descriptive, hospital  based study, 
conducted at Mycetoma Research Centre at Soba University 
Hospital . It aimed to study the clinical presentation of 
mycetoma in children less than eighteen years of age and their 
knowledge, attitude and practice towards the disease.  This 
study showed that mycetoma can occur in children similar to 
that reported by Gumaa S A(46)   who concluded that it does 
occur in children. Also agree with Develoux(32)  who reported 
Mycetoma in children . 
 The majority of cases were above ten year of age    ( 60.9  
%).  The male to female ratio is 3 :  1 which was in agree with 
study done in Mexico ( M : F = 4 : 1) (80).   
All patients were from rural areas from different parts of 
Sudan, but the central part had the highest percentage of 
patients which was in agreement with study done before in 
adults (46). 
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The lower limb was affected in 87.5% of the study group 
while the other part of the body constitutes for  (12.5 %) which 
was the same  with study done in Sudan in which  the foot was 
affected in (70%) of the study group(24) and Mexico where the 
foot was affected in 66.6% of the study group(80).  
 84.6% of patient presented after one year of infection, so 
there is delayed presentation to doctors as compared to study 
done in Somalia where they found that the patients had 
delayed presentation(34).  
 From those 62.7% presented with recurrent symptoms 
after treatment in other hospitals.  39.1% of the study group 
gave no history of previous trauma, in contrast to study done in 
west Bangal where they noticed that the pricking was the most 
common injury associated with eumycetes(37). 
39.1% of the study group gave history of mycetoma in 
their families who  were mainly rural inhabitants, this goes 
with study done in West Africa (34) and in Saudi Arabia (35).   
The majority of patients (65.5%) presented with both 
sinuses and masses. 
The majority of patients (73.6%) were diagnosed by 
histopathology after surgery. 
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In 95.5% of the study group fungal mycetoma was the 
commonest type, in contrast to study done in West Bangal 
where actinomycetoma predominated over eumycetoma (183 : 
81) (37),  and this also occured in Saudi Arabia (35), but it agrees 
with study done in Somalia (34) and Yemen (36)where fungal 
mycetoma predominate. 
31.8% of the study group had bone involvement and 2 
patients of them ended in amputation. 86.4% of the study group 
had some knowledge about the disease and all of them took 
these informations from their treating doctors.      
There were 32.7% of the study group who had some trial 
with traditional treatment, from which we noticed that there is 
no relation between uses of traditional treatment and affection 
of bone in the study group (P > 0.5), but there is strong 
correlation between the causative agent and affection of bone. 
Almost all cases due to bacterial type had bone involvement.  
While 85.7% of bone infection are caused by fungal mycetoma 
(P < 0.001). 
59.1% of the study group were adherent to treatment and 
used it regularly without interruption, but 42.9% of those with 
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bone infection were among those adherent to treatment, so 
there is strong relation between adherence to treatment and 
bone infection in the study group (P < 0.01). 
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Conclusion  
 
• Mycetoma commonly occurs in children especially these 
from rural area in Sudan. 
• It is less common in children less than 10 years of age and 
more common above 10 years of age. 
• Males predominate.  
• It affects the foot more frequently than the other parts of 
the body. 
• The majority had   late presentation. 
• Fungal mycetoma predominate the bacterial type (21:1). 
• The majority of patient were diagnosed after surgery by 
histopathology. 
• There was no obvious history of trauma in the majority of 
the study group. 
• The majority of patients were not aware about the 
disease; and those who had some knowledge, acquired it 
from the doctors and medical staff. So the multimedia had 
no role in the awareness of the population about the 
disease. 
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• The treatment of mycetoma is very expensive and there is 
no support from the Ministry of Health or hospstials nor 
the health insurance.  So some of the patient are not 
adherent to treatment and they end up by very serious 
complications. 
• There is no relation between the age of the patient and 
the affection of bone, but there is strong association 
between the long duration of the disease (more than one 
year) and the bone involvement which is very serious 
complication that will end up by amputation. 
• There is no association between the use of traditional 
treatment and bone involvement in the study group. 
• All cases of bacterial type have bone involvement 
irrespective of the duration. 
• Most of fungal mycetoma prevails in the central part of 
the Sudan, while the bacterial type prevails in the south 
and west. 
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Recommendations 
 
1.        To reduce the rate of mycetoma infection we need to raise 
the awareness of the people and medical staff  about the 
importance of early detection  . 
2.   Mycetoma control programmes are tobe incorporated  in the  
PHC programmes. 
3.      Availability of free treatment because the patients 
affected are from poor families .  
4.       Establishment of mycetoma centre in central region 
where most of the patient are coming .  
 
 
 
 
 
 
